Hacker News new | past | comments | ask | show | jobs | submit login

The hepatitis C cures was massively profitable. Gilead paid $11B for Pharmasset’s portfolio and everyone said they were dumb.

They then had sales of $10.4B in the first year on the market. That’s one year and one drug (they’ve developed newer drugs and launched those too).




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: